InvestorsHub Logo
Followers 35
Posts 6943
Boards Moderated 0
Alias Born 03/31/2020

Re: HDGabor post# 280535

Tuesday, 06/16/2020 1:34:44 PM

Tuesday, June 16, 2020 1:34:44 PM

Post# of 425944
This! Hindsight is to be avoided with more than just patents.

Amarin's litigation strategy, as unfortunate as it was, was completely in line with other investment characteristics of this 1-drug growth company. Binary, highly asymmetrical, etc.

BO suitors likely balked at a car they were merely "pretty sure" Amarin owned.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News